Ginsenoside-Rs3, a new diol-type ginseng saponin, selectively elevates protein levels of p53 and p21(WAF1) leading to induction of apoptosis in SK-HEP-1 cells

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 487-491

  Kim, Seong Ee ^a   Lee, Yong Hee ^a   Park, Jeong Hill ^a   Lee, Seung Ki ^a  

^a Seoul National University   (South Korea)

Author keywords

Apoptosis; Ginsenoside Rs3; p21(WAF1); p53; SK HEP 1 cells

Indexed keywords

CELL CYCLE PROTEIN; CELL PROTEIN; CYCLIN A; CYCLIN E; DNA FRAGMENT; GINSENG SAPONIN; PHOSPHOTRANSFERASE; PROTEIN P21; PROTEIN P27; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; GINSENOSIDE; SAPONIN;

ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DOWN REGULATION; DRUG SELECTIVITY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME ASSAY; FLOW CYTOMETRY; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; CELL CULTURE; CELL DIVISION; DOSE RESPONSE; DRUG EFFECT;

PANAX GINSENG;

APOPTOSIS; CELL DIVISION; CYCLIN A; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GINSENOSIDES; HUMANS; SAPONINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032588931     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Back NI, Kim DS, Lee YH, Park JD, Lee CB, Kim SI: Cytotoxicity of ginseng saponins and their degradation products against some cancer cell lines. Arch Pharm Res 18: 164-168, 1995.
2. Kitagawa I, Yoshikawa M, Yoshihara M, Hayashi T, Toniyama T: Chemical studies on crude drug precession. I. On the constituents of Ginseng Radix Ruba. Yakugaku Zasshi 103: 612-622, 1983.
3. Ota T, Fujikawa-yamamoto K, Zong Z-P, Yamazaki M, Odashima S: Plant-glycoside modulation of cell surface related to control of differentiation in cultured B16 melanoma cells. Cancer Res 47: 3863-3867, 1987.
4. Ota T, Maeda M, Odashima S: Mechanism of action of Ginsenoside-Rh2: Uptake and metabolism of Ginsenoside-Rh2 by cultured B16 melanoma cells. J Pharm Sci 80: 1141-1146, 1991.
5. Kip1. Cancer Lett 110: 193-200, 1996.
6. Park JA, Kim K-W, Lee SK: Activation of caspase-3 protease via a Bcl-2-insensitive pathways during the process of ginsenoside Rh2-induced apoptosis. Cancer Lett 121: 73-81, 1997.
7. Waf1 with concomitant down-regulation of cdc25A in SK-HEP-1 cells. Anticancer Res 17: 1067-1072, 1997.
8. Back NI, Kim JM, Park JH, Ryu JH, Kim DS, Lee YH, Park JD, Kim SI: Ginsenoside Rs3, a genuine dammarane-glycoside from Korean red ginseng. Arch Pharm Res 20: 280-282, 1997.
9. Sherr CJ: Mammalian G1 cyclins. Cell 73: 1059-1065, 1993.
10. Morgan DO: Principles of CDK regulation. Nature 374: 131-134, 1995.
11. Hunter T, Pines J: Cyclins and Cancer II: cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994.
12. DeBondt HL, Rosenblatt J, Jancarik J, Jones HD, Morgan DO, Kim SH: Crystal structure of cyclin-dependent kinase 2. Nature 363: 595-602, 1993.
13. Morgan DO, DeBondt HL: Protein kinase regulation: insights from crystal structure analysis. Curr Opin Cell Biol 6: 239-246, 1994.
14. Gu Y, Turck CW, Morgan DO: Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707-710, 1993.
15. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
16. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cvclin kinases. Nature 366: 701-704, 1993.
17. Peter M, Herskowitz I: Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79: 181-184, 1994.
18. Elledge SJ, Harper JW: Cdk inhibitors: on the threshold of checkpoints and developments. Curr Opin Cell Biol 6: 847-852, 1994.
19. El-Deiry W, Tokino T, Velculescu VE, Levy DB, Parson R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 79: 817-825, 1993.
20. Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578, 1994.